Analyst Price Targets — FSNUY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 3, 2023 4:57 am | James Vane-Tempest | Jefferies | $9.30 | $6.99 | TheFly | Fresenius SE upgraded to Buy on restructuring benefits at Jefferies |
Latest News for FSNUY
Fresenius SE & Co. KGaA (FSNUY) Q4 2025 Earnings Call Transcript
Fresenius SE & Co. KGaA (FSNUY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Fresenius SE and Co. (OTCMKTS:FSNUY - Get Free Report) and U.S. Physical Therapy (NYSE: USPH - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Earnings and Valuation This table
Fresenius SE & Co. KGaA (FSNUY) Analyst/Investor Day Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for FSNUY.
Senate Trading
No Senate trades found for FSNUY.
U.S. House Trading
No House trades found for FSNUY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.